Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
17beta-estradiol + 3'-phosphoadenylyl sulfate
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phopshoadenylyl sulfate + resveratrol
adenosine 3',5'-bisphosphate + resveratrol 3-O-sulfate + resveratrol 4'-O-sulfate + resveratrol 3,4'-O-disulfate
-
i.e. 3,5,4'-trihydroxystilbene, a phytoestrogen with mixed estrogen agonist/antagonist properties developed as a chemopreventive agent, interaction of resveratrol with 17beta-estradiol, overview
three different sulfate products, product identification by NMR, overview
-
?
3'-phosphoadenylyl sulfate + 1-naphthol
adenosine 3',5'-bisphosphate + 1-naphthyl sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + 2-methyl-17beta-estradiol
adenosine 3',5'-bisphosphate + 2-methyl-17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 3,4-dihydroxyphenylacetic acid
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 3-cyano-7-hydroxycoumarin
adenosine 3',5'-bisphosphate + 3-cyano-7-hydroxycoumaryl sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 3alpha-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + 3beta-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + 4-nitrophenol
adenosine 3',5'-bisphosphate + 4-nitrophenyl sulfate
3'-phosphoadenylyl sulfate + 6-hydroxy-4-methylbenzo[d]thiazole-2-carbonitrile
adenosine 3',5'-bisphosphate + ?
i.e. proluciferin substrate UGT-Glo substrate A, GSA
-
-
?
3'-phosphoadenylyl sulfate + apigenin
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + beta-estradiol
adenosine 3',5'-bisphosphate + beta-estradiol 3-sulfate
3'-phosphoadenylyl sulfate + chrysin
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + desipramine
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + diethylstilbestrol
adenosine 3',5'-bisphosphate + diethylstilbestrol sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + epicatechin
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrogen
adenosine 3',5'-bisphosphate + estrogen 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
3'-phosphoadenylyl sulfate + ethinyl estradiol
adenosine 3',5'-bisphosphate + ethinyl estradiol 3-sulfate
-
a synthetic oral contraceptive, low activity
-
-
?
3'-phosphoadenylyl sulfate + L-triiodothyronine
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + quercetin
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + resveratrol
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + tamoxifen
adenosine 3',5'-bisphosphate + tamoxifen sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + testosterone
adenosine 3',5'-bisphosphate + testosterone sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + xanthurenic acid
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylylsulfate + 17alpha ethinyl estradiol
adenosine 3',5'-bisphosphate + 17alpha ethinyl estradiol 3-sulfate
3'-phosphoadenylylsulfate + 17alpha-ethinylestradiol
adenosine 3',5'-bisphosphate + ?
-
isoform SULT1A3
-
-
?
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
?
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
3'-phosphoadenylylsulfate + 2-OH-1,3,7,8-tetrachlorinated dibenzo-p-dioxine
adenosine 3',5'-bisphosphate + 2-OH-1,3,7,8-tetrachlorinated dibenzo-p-dioxine sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-1,3,7,8-tetrachlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 2-OH-1,3,7,8-tetrachlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-3,7,8-trichlorinated dibenzo-p-dioxine
adenosine 3',5'-bisphosphate + 2-OH-3,7,8-trichlorinated dibenzo-p-dioxine sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-4,2',4'-trichlorodiphenyl ether
adenosine 3',5'-bisphosphate + 2-OH-4,2',4'-trichlorodiphenyl ethyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-4,5,3',2',3',4'-tetrachlorated biphenyl
adenosine 3',5'-bisphosphate + 2-OH-4,5,3',4'-tetrachlorated biphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-6,7,8-trichlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 2-OH-6,7,8-trichlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-7,8-dichlorinated dibenzo-p-dioxine
adenosine 3',5'-bisphosphate + 2-OH-7,8-dichlorinated dibenzo-p-dioxine sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 2-OH-7,8-dichlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 2-OH-7,8-dichlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3,5,3',5'-tetrabromo-4,4'-isopropylidendiphenol
adenosine 3',5'-bisphosphate + 3,5,3',5'-tetrabromo-4,4'-isopropylidendiphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3,5,3',5'-tetrachloro-4,4'-isopropylidendiphenol
adenosine 3',5'-bisphosphate + 3,5,3',5'- tetrachloro-4,4'-isopropylidendiphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3-OH-2,4,7,8-tetrachlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 3-OH-2,4,7,8-tetrachlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3-OH-2,6,7,8,9-pentachlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 3-OH-2,6,7,8,9-pentachlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3-OH-2,6,7,8-tetrachlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 3-OH-2,6,7,8-tetrachlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 3-OH-4,5,3',4'-tetrachlorated biphenyl
adenosine 3',5'-bisphosphate + 3-OH-4,5,3',4'-tetrachlorated biphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4,4'-(OH)2-3,5,3',5'-tetrachlorated biphenyl
adenosine 3',5'-bisphosphate + 4,4'-(OH)2-3,5,3',5'-tetrachlorated biphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-hydroxy-2,3,5,3',4'-pentachlorobiphenyl
adenosine 3',5'-bisphosphate + 4-hydroxy-2,3,5,3',4'-pentachlorobiphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-hydroxy-3,2',3',4',5'-pentachlorobiphenyl
adenosine 3',5'-bisphosphate + 4-hydroxy-3,2',3',4',5'-pentachlorobiphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-OH-1,3,6,7-tetrachlorinated dibenzofuran
adenosine 3',5'-bisphosphate + 4-OH-1,3,6,7-tetrachlorinated dibenzofuranyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-OH-2',4',6'-tribromodiphenyl ether
adenosine 3',5'-bisphosphate + 4-OH-2',4',6'-tribromodiphenyl ethyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-OH-3',2',4',6'-tetrabromodiphenyl ether
adenosine 3',5'-bisphosphate + 4-OH-3',2',4',6'-tetrabromodiphenyl ethyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-OH-3',5,2',4',6'-pentabromodiphenyl ether
adenosine 3',5'-bisphosphate + 4-OH-3',5,2',4',6'- pentabromodiphenyl ethyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + 4-OH-3,3',4'-trichlorated biphenyl
adenosine 3',5'-bisphosphate + 4-OH-3,3',4'-trichlorated biphenyl sulfate
-
-
-
-
r
3'-phosphoadenylylsulfate + butylated hydroxyanisole
adenosine 3',5'-bisphosphate + butylated hydroxyanisole sulfate
-
-
r
3'-phosphoadenylylsulfate + catechin hydrate
adenosine 3',5'-bisphosphate + catechin hydrate sulfate
-
-
r
3'-phosphoadenylylsulfate + daidzein
adenosine 3',5'-bisphosphate + daidzein sulfate
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
3'-phosphoadenylylsulfate + dopamine
adenosine 3',5'-bisphosphate + dopamine sulfate
3'-phosphoadenylylsulfate + epicatechin
adenosine 3',5'-bisphosphate + epicatechin sulfate
-
-
r
3'-phosphoadenylylsulfate + epigallocatechin gallate
adenosine 3',5'-bisphosphate + epigallocatechin gallate sulfate
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
-
?
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
3'-phosphoadenylylsulfate + estriol
adenosine 3',5'-bisphosphate + estriol 3-sulfate
3'-phosphoadenylylsulfate + estrogen
adenosine 3',5'-bisphosphate + estrogen sulfate
-
-
-
?
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
3'-phosphoadenylylsulfate + genistein
adenosine 3',5'-bisphosphate + genistein 7-sulfate + genistein 4'-sulfate
-
-
r
3'-phosphoadenylylsulfate + kaempferol
adenosine 3',5'-bisphosphate + kaempferol sulfate
-
-
r
3'-phosphoadenylylsulfate + myricetin
adenosine 3',5'-bisphosphate + myricetin sulfate
-
-
r
3'-phosphoadenylylsulfate + n-propyl gallate
adenosine 3',5'-bisphosphate + n-propyl gallate sulfate
-
-
r
3'-phosphoadenylylsulfate + p-nitrophenol
adenosine 3',5'-bisphosphate + p-nitrophenyl sulfate
3'-phosphoadenylylsulfate + pregnenolone
adenosine 3',5'-bisphosphate + pregnenolone 3-sulfate
3'-phosphoadenylylsulfate + quercetin
adenosine 3',5'-bisphosphate + quercetin sulfate
3'-phosphoadenylylsulfate + resveratrol
adenosine 3',5'-bisphosphate + resveratrol sulfate
-
-
-
r
additional information
?
-
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
17beta-estradiol regulates growth and differentiation in normal and malignant bone, it is inactivated to 17beta-estradiol-sulfate through SULT1E1
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
hSULT1E1 catalyzes the sulfation of estrogens and regulates estrogen bioactivities
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
the active site of hSULT1E1 contains Cys residues. Cys83 is critical for the redox regulation of hSULT1E1
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
SULT1E1 has a high affinity and catalytic efficiency for estradiol as substrate
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
-
r
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 3alpha-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 3alpha-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis
-
-
?
3'-phosphoadenylyl sulfate + 3beta-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 3beta-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis
-
-
?
3'-phosphoadenylyl sulfate + 4-nitrophenol
adenosine 3',5'-bisphosphate + 4-nitrophenyl sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 4-nitrophenol
adenosine 3',5'-bisphosphate + 4-nitrophenyl sulfate
-
reaction of phenol sulfonyltransferase, EC 2.8.2.1, determination of reaction equilibrium in the forward direction at 70% of conversion of 4-nitrophenol
-
-
r
3'-phosphoadenylyl sulfate + beta-estradiol
adenosine 3',5'-bisphosphate + beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + beta-estradiol
adenosine 3',5'-bisphosphate + beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
-
-
-
-
?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
SULT1E1 is involved in estrogen inactivation
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
high activity by SULT1E1, low activity by SULT1A1, EC 2.8.2.1
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
isozyme SULT1E1 is specific for estradiol sulfonation, interaction of resveratrol with 17beta-estradiol, overview
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
EST expression and regulation in invasive breast cancer and ductal carcinoma in situ, overview
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
estradiol sulfate is biologically inactive, the conversion of estradiol to its sulfate prevents it from binding to and thereby activating the estrogen receptor
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
SULT1E1 acts at nanomolar concentration of estradiol. SULT1A1 is active at micromolar concentration of estradiol and has an affinity 300fold lower than SULT1E1
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
-
r
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
SULT1E1 is involved in estrogen inactivation
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
high activity by SULT1E1, low activity by phenol sulfotransferase SULT1A1, EC 2.8.2.1
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
estrone sulfate is biologically inactive, the conversion of estradiol to its sulfate prevents it from binding to and thereby activating the estrogen receptor
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
hSULT1E1 catalyzes the sulfation of estrogens and regulates estrogen bioactivities
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
the active site of hSULT1E1 contains Cys residues. Cys83 is critical for the redox regulation of hSULT1E1
-
-
?
3'-phosphoadenylylsulfate + 17alpha ethinyl estradiol
adenosine 3',5'-bisphosphate + 17alpha ethinyl estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17alpha ethinyl estradiol
adenosine 3',5'-bisphosphate + 17alpha ethinyl estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17alpha ethinyl estradiol
adenosine 3',5'-bisphosphate + 17alpha ethinyl estradiol 3-sulfate
-
-
r
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dopamine
adenosine 3',5'-bisphosphate + dopamine sulfate
-
-
-
r
3'-phosphoadenylylsulfate + dopamine
adenosine 3',5'-bisphosphate + dopamine sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
best substrate
-
r
3'-phosphoadenylylsulfate + estriol
adenosine 3',5'-bisphosphate + estriol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estriol
adenosine 3',5'-bisphosphate + estriol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
-
-
-
-
?
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
-
-
-
?
3'-phosphoadenylylsulfate + p-nitrophenol
adenosine 3',5'-bisphosphate + p-nitrophenyl sulfate
-
-
-
r
3'-phosphoadenylylsulfate + p-nitrophenol
adenosine 3',5'-bisphosphate + p-nitrophenyl sulfate
-
-
-
r
3'-phosphoadenylylsulfate + p-nitrophenol
adenosine 3',5'-bisphosphate + p-nitrophenyl sulfate
-
model substrate, sulfonated by SULT1E1
-
r
3'-phosphoadenylylsulfate + pregnenolone
adenosine 3',5'-bisphosphate + pregnenolone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + pregnenolone
adenosine 3',5'-bisphosphate + pregnenolone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + quercetin
adenosine 3',5'-bisphosphate + quercetin sulfate
-
-
-
r
3'-phosphoadenylylsulfate + quercetin
adenosine 3',5'-bisphosphate + quercetin sulfate
-
-
r
additional information
?
-
-
dopamine is no substrate
-
-
?
additional information
?
-
caffeic acid, chlorogenic acid, BHT, and gallic acid are no substrates
-
-
?
additional information
?
-
-
1-hydroxy-2,4,7,8-tetrachlorodibenzofuran is no substrate
-
-
?
additional information
?
-
-
knockout of the cystic fibrosis transmembrane conductance regulator, CFTR, leads to increased SULT1E1 expression, estrogen levels play a role in development of cystic fibrosis
-
-
?
additional information
?
-
-
local production of estrogens in human peripheral tissues and/or breast carcinoma, overview
-
-
?
additional information
?
-
-
local regulation of estradiol and EST in ductal carcinoma, DCIS, correlation between aromatase and EST expression and grade of malignancy in ductal carcinoma, overview
-
-
?
additional information
?
-
-
phytoestrogens can potentially alter the homeostasis of estrogen levels
-
-
?
additional information
?
-
-
progestins, which activate the enzyme decrease cell proliferation of breast cancer cell lines, overview
-
-
?
additional information
?
-
-
SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals. This reaction increases the water solubility of the molecule, which may affect its cellular distribution and biological activity, and alter estrogen signaling to the estrogen receptor in human estrogen receptor-positive cells
-
-
?
additional information
?
-
SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals. This reaction increases the water solubility of the molecule, which may affect its cellular distribution and biological activity, and alter estrogen signaling to the estrogen receptor in human estrogen receptor-positive cells
-
-
?
additional information
?
-
SULTs play a role in the metabolism of regulatory hormones, drugs, and carcinogens, they catalyze the sulfonation of simple phenols, estradiol, and thyroid hormones, as well as environmental xenobiotics and drugs, overview
-
-
?
additional information
?
-
role for 3'-phosphoadenylyl sulfate in priming the conformation of substrate binding loops, overview, substrate specificity and binding structure of SULT1E1, overview
-
-
?
additional information
?
-
-
the reaction is also performed by the phenol sulfotranferase, EC 2.8.2.1, but with lower activity
-
-
?
additional information
?
-
-
chronic topical application of parabens may lead to prolonged estrogenic effects in skin as a result of inhibition of estrogen sulfotransferase activity, overview. The skin anti-aging benefits of many topical cosmetics and pharmaceuticals could be derived, in part, from the estrogenicity of parabens
-
-
?
additional information
?
-
-
concerted action of catechol-O-methyltransferase and the cytosolic sulfotransferase, SULT, enzyme(s) in the metabolism of catecholestrogens with production of sulfated 2-methoxy-estrone or sulfated 2- or 4-methoxy-estradiol, overview
-
-
?
additional information
?
-
-
cytosolic sulfotransferase SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals
-
-
?
additional information
?
-
cytosolic sulfotransferase SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals
-
-
?
additional information
?
-
-
EST catalyzes the transfer of a sulfuryl group to estrogens and might be involved in endometriosis, an estrogen-dependent gynecological disease, characterized by implantation and invasive growth of endometrial tissue outside the uterine cavity, causing pelvic pain and infertility. Impaired estrogen metabolism plays a pivotal role in the pathogenesis of the disease, overview
-
-
?
additional information
?
-
-
estrogen exposure is a risk factor for gallstone disease, cholelithiasis, which often leads to chronic inflammation, cholecystitis. SULT1E1 is a key enzymes involved in the inactivation of estrogens. Estrogen concentrations in human gallbladder are regulated by a network of activating STS and inactivating SULT1E1, and estrogen receptors alpha and beta, localization in tissue, overview
-
-
?
additional information
?
-
-
SULT1E1 and ID2 genes are candidates for inherited predisposition to breast and ovarian cancer in Jewish women
-
-
?
additional information
?
-
-
SULT1E1 catalyzes the sulfate conjugation of estrone, estradiol, catecholestrogens, and 2-methyl-estradiol. SULT1E1 polymorphisms, together with other SULT enzyme polymorphisms, are risk factors for endometrial cancer susceptibility
-
-
?
additional information
?
-
-
SULT1E1 has a major role in estrogen conjugation. Important role for SULT isozymes and their pharmacogenetics in polyphenol disposition
-
-
?
additional information
?
-
SULT1E1 has a major role in estrogen conjugation. Important role for SULT isozymes and their pharmacogenetics in polyphenol disposition
-
-
?
additional information
?
-
-
SULT1E1 is involved in breast cancer cell proloferation, overview
-
-
?
additional information
?
-
-
SULT1E1 or EST is an enzyme important for the metabolic deactivation of estrogens, because sulfonated estrogens fail to activate the estrogen receptor. ectopic expression of SULT1E1 in MCF-7 cells suppresses the estrogen response. SULT1E1 is a transcriptional target of the glucocorticoid receptor, molecular mechanism, overview
-
-
?
additional information
?
-
-
SULT1E1 plays a regulatory role in estrogen signaling activities in human reproductive cells, including the prostate cells. SULT1E1 may function as a transcriptional mediator in transfected human prostate cancer CA-HPV-10 cells, molecular mechanism, overview
-
-
?
additional information
?
-
-
the endocrinological status of women bearing polycystic ovarian syndrome, PCOS, affects the endometrial in situ steroid metabolism, which involves EST, overview
-
-
?
additional information
?
-
-
the enzyme responsible for the formation of the biologically inactive estrogen sulfates
-
-
?
additional information
?
-
-
the redox regulation of hSULT1E1 may interrupt the regulation and function of estrogens under various physiological and pathological conditions
-
-
?
additional information
?
-
-
differential sulfating activities of the human SULTs toward catecholestrogens and nethoxyestrogens, overview
-
-
?
additional information
?
-
SULT1E1 catalyzes the sulfation of estradiol and other phenolic steroids
-
-
-
additional information
?
-
EST has a particularly high affinity for estrogens as substrates including estradiol (17beta-estradiol), estrone, and a variety of synthetic estrogens, like diethylstilbestrol and tamoxifen. EST also exhibits a low affinity for thyroid hormones, testosterones, or glucocorticoids
-
-
-
additional information
?
-
human estrogen sulfotransferase and its related fluorescently labeled decapeptides with a YKDG sequence specifically interact with oxidized low-density lipoprotein. Interaction between human SULT1E1 (hSULT1E1), which has a YKEG sequence (residues 61-64) unlike other human SULTs, and Ox-LDL. hSULT1E1 specifically binds to Ox-LDL and its major lipid component (lysophosphatidylcholine, LPC), and platelet-activating factor (PAF), which bear a marked resemblance to LPC in terms of structure and activity. An N-terminally fluorescein isothiocyanate (FITC)-labeled decapeptide (MIYKEGDVEK, FITC-hSULT1E1-P10) corresponding to residues 59-68 of hSULT1E1 also specifically binds to Ox-LDL, LPC, and PAF
-
-
-
additional information
?
-
-
human estrogen sulfotransferase and its related fluorescently labeled decapeptides with a YKDG sequence specifically interact with oxidized low-density lipoprotein. Interaction between human SULT1E1 (hSULT1E1), which has a YKEG sequence (residues 61-64) unlike other human SULTs, and Ox-LDL. hSULT1E1 specifically binds to Ox-LDL and its major lipid component (lysophosphatidylcholine, LPC), and platelet-activating factor (PAF), which bear a marked resemblance to LPC in terms of structure and activity. An N-terminally fluorescein isothiocyanate (FITC)-labeled decapeptide (MIYKEGDVEK, FITC-hSULT1E1-P10) corresponding to residues 59-68 of hSULT1E1 also specifically binds to Ox-LDL, LPC, and PAF
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3'-phosphoadenylyl sulfate + 1-naphthol
adenosine 3',5'-bisphosphate + 1-naphthyl sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + 2-methyl-17beta-estradiol
adenosine 3',5'-bisphosphate + 2-methyl-17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 3,4-dihydroxyphenylacetic acid
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 3alpha-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis
-
-
?
3'-phosphoadenylyl sulfate + 3beta-hydroxytibolone
adenosine 3',5'-bisphosphate + ?
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis
-
-
?
3'-phosphoadenylyl sulfate + 4-nitrophenol
adenosine 3',5'-bisphosphate + 4-nitrophenyl sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + beta-estradiol
adenosine 3',5'-bisphosphate + beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + desipramine
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + diethylstilbestrol
adenosine 3',5'-bisphosphate + diethylstilbestrol sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrogen
adenosine 3',5'-bisphosphate + estrogen 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
3'-phosphoadenylyl sulfate + L-triiodothyronine
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + tamoxifen
adenosine 3',5'-bisphosphate + tamoxifen sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + testosterone
adenosine 3',5'-bisphosphate + testosterone sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + xanthurenic acid
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylylsulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
?
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
3'-phosphoadenylylsulfate + estrogen
adenosine 3',5'-bisphosphate + estrogen sulfate
-
-
-
?
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
additional information
?
-
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
17beta-estradiol regulates growth and differentiation in normal and malignant bone, it is inactivated to 17beta-estradiol-sulfate through SULT1E1
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol 3-sulfate
-
hSULT1E1 catalyzes the sulfation of estrogens and regulates estrogen bioactivities
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + 17beta-estradiol sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + 17beta-estradiol
adenosine 3',5'-bisphosphate + ?
-
-
-
-
r
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
-
-
-
-
?
3'-phosphoadenylyl sulfate + dehydroepiandrosterone
adenosine 3',5'-bisphosphate + ?
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
SULT1E1 is involved in estrogen inactivation
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
EST expression and regulation in invasive breast cancer and ductal carcinoma in situ, overview
-
-
?
3'-phosphoadenylyl sulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
estradiol sulfate is biologically inactive, the conversion of estradiol to its sulfate prevents it from binding to and thereby activating the estrogen receptor
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
SULT1E1 is involved in estrogen inactivation
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
estrone sulfate is biologically inactive, the conversion of estradiol to its sulfate prevents it from binding to and thereby activating the estrogen receptor
-
-
?
3'-phosphoadenylyl sulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
hSULT1E1 catalyzes the sulfation of estrogens and regulates estrogen bioactivities
-
-
?
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estradiol
adenosine 3',5'-bisphosphate + estradiol 3-sulfate
-
best substrate
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone 3-sulfate
-
-
r
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
-
-
-
-
?
3'-phosphoadenylylsulfate + estrone
adenosine 3',5'-bisphosphate + estrone sulfate
-
-
-
?
additional information
?
-
-
knockout of the cystic fibrosis transmembrane conductance regulator, CFTR, leads to increased SULT1E1 expression, estrogen levels play a role in development of cystic fibrosis
-
-
?
additional information
?
-
-
local production of estrogens in human peripheral tissues and/or breast carcinoma, overview
-
-
?
additional information
?
-
-
local regulation of estradiol and EST in ductal carcinoma, DCIS, correlation between aromatase and EST expression and grade of malignancy in ductal carcinoma, overview
-
-
?
additional information
?
-
-
phytoestrogens can potentially alter the homeostasis of estrogen levels
-
-
?
additional information
?
-
-
progestins, which activate the enzyme decrease cell proliferation of breast cancer cell lines, overview
-
-
?
additional information
?
-
-
SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals. This reaction increases the water solubility of the molecule, which may affect its cellular distribution and biological activity, and alter estrogen signaling to the estrogen receptor in human estrogen receptor-positive cells
-
-
?
additional information
?
-
SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals. This reaction increases the water solubility of the molecule, which may affect its cellular distribution and biological activity, and alter estrogen signaling to the estrogen receptor in human estrogen receptor-positive cells
-
-
?
additional information
?
-
SULTs play a role in the metabolism of regulatory hormones, drugs, and carcinogens, they catalyze the sulfonation of simple phenols, estradiol, and thyroid hormones, as well as environmental xenobiotics and drugs, overview
-
-
?
additional information
?
-
-
chronic topical application of parabens may lead to prolonged estrogenic effects in skin as a result of inhibition of estrogen sulfotransferase activity, overview. The skin anti-aging benefits of many topical cosmetics and pharmaceuticals could be derived, in part, from the estrogenicity of parabens
-
-
?
additional information
?
-
-
concerted action of catechol-O-methyltransferase and the cytosolic sulfotransferase, SULT, enzyme(s) in the metabolism of catecholestrogens with production of sulfated 2-methoxy-estrone or sulfated 2- or 4-methoxy-estradiol, overview
-
-
?
additional information
?
-
-
cytosolic sulfotransferase SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals
-
-
?
additional information
?
-
cytosolic sulfotransferase SULT1E1 catalyzes the sulfation of endogenous estrogens as well as xenobiotic estrogen-like chemicals
-
-
?
additional information
?
-
-
EST catalyzes the transfer of a sulfuryl group to estrogens and might be involved in endometriosis, an estrogen-dependent gynecological disease, characterized by implantation and invasive growth of endometrial tissue outside the uterine cavity, causing pelvic pain and infertility. Impaired estrogen metabolism plays a pivotal role in the pathogenesis of the disease, overview
-
-
?
additional information
?
-
-
estrogen exposure is a risk factor for gallstone disease, cholelithiasis, which often leads to chronic inflammation, cholecystitis. SULT1E1 is a key enzymes involved in the inactivation of estrogens. Estrogen concentrations in human gallbladder are regulated by a network of activating STS and inactivating SULT1E1, and estrogen receptors alpha and beta, localization in tissue, overview
-
-
?
additional information
?
-
-
SULT1E1 and ID2 genes are candidates for inherited predisposition to breast and ovarian cancer in Jewish women
-
-
?
additional information
?
-
-
SULT1E1 catalyzes the sulfate conjugation of estrone, estradiol, catecholestrogens, and 2-methyl-estradiol. SULT1E1 polymorphisms, together with other SULT enzyme polymorphisms, are risk factors for endometrial cancer susceptibility
-
-
?
additional information
?
-
-
SULT1E1 has a major role in estrogen conjugation. Important role for SULT isozymes and their pharmacogenetics in polyphenol disposition
-
-
?
additional information
?
-
SULT1E1 has a major role in estrogen conjugation. Important role for SULT isozymes and their pharmacogenetics in polyphenol disposition
-
-
?
additional information
?
-
-
SULT1E1 is involved in breast cancer cell proloferation, overview
-
-
?
additional information
?
-
-
SULT1E1 or EST is an enzyme important for the metabolic deactivation of estrogens, because sulfonated estrogens fail to activate the estrogen receptor. ectopic expression of SULT1E1 in MCF-7 cells suppresses the estrogen response. SULT1E1 is a transcriptional target of the glucocorticoid receptor, molecular mechanism, overview
-
-
?
additional information
?
-
-
SULT1E1 plays a regulatory role in estrogen signaling activities in human reproductive cells, including the prostate cells. SULT1E1 may function as a transcriptional mediator in transfected human prostate cancer CA-HPV-10 cells, molecular mechanism, overview
-
-
?
additional information
?
-
-
the endocrinological status of women bearing polycystic ovarian syndrome, PCOS, affects the endometrial in situ steroid metabolism, which involves EST, overview
-
-
?
additional information
?
-
-
the enzyme responsible for the formation of the biologically inactive estrogen sulfates
-
-
?
additional information
?
-
-
the redox regulation of hSULT1E1 may interrupt the regulation and function of estrogens under various physiological and pathological conditions
-
-
?
additional information
?
-
SULT1E1 catalyzes the sulfation of estradiol and other phenolic steroids
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+)-6beta-hydroxy-15,16-epoxylabda-8,13(16),14-trien-7-one
-
(-)-6,9:15,16-diepoxy-9alpha-hydroxy-8,9-seco-13(16),14-labdadiene-7-one
-
16alpha-hydroxyestrone
-
maximum inhibition at 100 nM
2,2',3',4,4',5,5'-heptachloro[1,1'-biphenyl]-3-ol
-
-
2,2',5,5'-tetrachloro-4-hydroxybiphenyl
-
-
2,3',4-trichloro-4'-hydroxybiphenyl
the inhibitor has been identified as a metabolite in human plasma with an estimated half-life of 6.5 years
-
2,4'-dichloro-4-hydroxybiphenyl
-
-
2,4,6-Trichlorophenol
-
-
2,6-Dichloro-4-nitrophenol
2-hydroxy-1,3,7,8-tetrachlorodibenzo-p-dioxin
-
-
2-hydroxy-3,4,2',3',4'-pentachlorobiphenyl
-
-
2-hydroxy-3,4,3',4'-tetrachlorobiphenyl
-
-
2-hydroxy-4,5,3',4'-tetrachlorobiphenyl
-
-
2-hydroxy-7,8-dichlorodibenzo-p-dioxin
-
-
2-hydroxy-7,8-dichlorodibenzofuran
-
-
2-OH-3,2'-dibromobiphenyl
-
-
3',4',7-trihydroxyisoflavone
-
-
3'-phosphoadenylylsulfate
-
-
3,3',5,5'-tetrachlorobisphenol A
-
-
3,3'-(hydroxy)2-4,4'-dichlorobiphenyl
-
-
3,3'-dichloro-4-hydroxybiphenyl
-
-
3,5-dibromo-4-hydroxy-benzoic acid (6-chloro-4-oxo-4H-chromen-3-ylmethylene)-hydrazide
DBHM
3,5-dibromo-4-hydroxybenzoic acid (6,8-dichloro-4-oxo-4H-chromen-3-ylmethylene) hydrazide
DBHD
3-hydroxy-2,4,5,3',4'-pentachlorobiphenyl
-
-
3-hydroxy-2,4,7,8,9-pentachlorodibenzofuran
-
-
3-hydroxy-2,4,7,8-tetrachlorodibenzofuran
-
-
3-hydroxy-4,5,2',3',4'-pentachlorobiphenyl
-
-
3-hydroxy-4,5,3',4',5'-pentachlorobiphenyl
-
-
3-hydroxy-4,5,3',4'-tetrachlorobiphenyl
-
-
3-OH-2,2'-dibromobiphenyl
-
-
3-OH-4,4'-dibromobiphenyl
-
-
3alpha-tibolone
-
activates SULT1E1 in MCF-7 cells by 50% and 37% at low concentrations of 50 nM and 500 nM, respectively, inhibits at 0.05 mM by 63%
3beta-tibolone
-
activates SULT1E1 in MCF-7 cells by 101% and 74% at low concentrations of 50 nM and 500 nM, respectively, inhibits at 0.05 mM by 54%
4,4'-(hydroxy)2-3,5,'3',5'-tetrachlorobiphenyl
-
-
4,4'-isopropyl idenediphenol-3,3',5,5'-tetrachlorobisphenol
-
-
4,4'-isopropylidenediphenol
-
-
4-chloro-4'-hydroxybiphenyl
-
-
4-ene tibolone
-
inhibits at high concentrations of 0.05 mM by 59%
4-hydroxy-2',3',4',5'-tetrachlorobiphenyl
-
-
4-hydroxy-2',4',6'-trichlorobiphenyl
-
-
4-hydroxy-2,2',3',4',5'-pentachlorobiphenyl
-
-
4-hydroxy-2,2',3',4',6'-pentachlorobiphenyl
-
-
4-hydroxy-2,2',3',5',6'-pentachlorobiphenyl
-
-
4-hydroxy-2,2',4',6'-tetrachlorobiphenyl
-
-
4-hydroxy-2,3,4,5,6-pentabromodiphenylether
-
-
4-hydroxy-2,3,5,2',3',4',5'-heptachlorobiphenyl
-
-
4-hydroxy-2,3,5,2',3',4'-hexachlorobiphenyl
-
-
4-hydroxy-2,3,5,2',4',5'-hexachlorobiphenyl
-
-
4-hydroxy-2,3,5,3',4'-pentachlorobiphenyl
-
-
4-hydroxy-2,3,5,6,2',4',5'-heptachlorobiphenyl
-
-
4-hydroxy-3,2',3',4',5'-pentachlorobiphenyl
-
-
4-hydroxy-3,2',3',4',6'-pentachlorobiphenyl
-
-
4-hydroxy-3,2',3',5',6'-pentachlorobiphenyl
-
-
4-hydroxy-3,2',4',6'-tetrachlorobiphenyl
-
-
4-hydroxy-3,3',4'-trichlorobiphenyl
-
-
4-hydroxy-3,5,2',3',4',5'-hexachlorobiphenyl
-
-
4-hydroxy-3,5,2',3',4'-pentachlorobiphenyl
-
-
4-hydroxy-3,5,3',4',5'-pentachlorobiphenyl
-
-
4-hydroxy-3,5,3',4'-tetrachlorobiphenyl
-
-
4-hydroxy-3,5,3',5'-tetrachlorobiphenyl
-
-
4-hydroxybenzoate esters
-
i.e.parabens, structure-activity relationship, overview
4-hydroxybenzoic acid
-
-
4-OH-2,2'-dibromobiphenyl
-
-
4-OH-3,4'-dibromobiphenyl
-
-
4-OH-4'-monobromobiphenyl
-
-
5,7-dichlorokynurenic acid
-
6-OH-2,2'-dibromobiphenyl
-
-
abiraterone
antiandrogen drug, metabolite abiraterone, not the parent drug abiraterone acetate, is responsible for the inhibition
Acetylsalicylate
binds near enough to the substrate site to prevent catalysis but not affect dissociation of the substrate-enzyme complex
adenosine 5'-(beta,gamma-imido) triphosphate
i.e. AMP-PNP, a non-hydrolysable ATP analogue
buthionine sulfoxamine
-
a GSH depletor, decreases SULT1E1 activity, but fails to affect the enzyme amount in Hep-G2 cells
butylparaben
-
50% inhibition at 0.021 mM, complete inhibition at 1 mM; strong inhibition, which is threefold higher in vivo than in vitro
chloroform
-
excess chloroform inactivates
daidzein 4,7-bissulfate
-
IC50: 0.01 mM
equol
-
potent mixed type inhibitor
ethylparaben
-
50% inhibition at 0.080 mM
galeterone
antiandrogen drug
gavestinel
i.e. 4,6-dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]-1H-indole-2-carboxylic acid sodium salt
genistein
-
potent mixed type inhibitor
GSSG
-
oxidized glutathione, inactivation and kinetics, adenosine 3'-phosphate 5'-phosphosulfate protects
hydroxylated polychlorated biphenyls
-
-
-
ICI 182,720
-
produces a marked decrease (over 50%) of EST activity with respect to untreated control cell cultures at 24 h
L689,560
i.e. trans-2-carboxy-5,7-dichloro-4-phenylaminocarboxylamino-1,2,3,4-tetrahydroquinoline
L701,324
i.e. 7-chloro-4-hydroxy-3(3-phenoxy)phenyl-2(H)-quinolinone
leosibiric acid A
most potent inhibition
meclofenamate
binds near enough to the substrate site to prevent catalysis but not affect dissociation of the substrate-enzyme complex
medrogestone
-
biphasic effect, inhibits at high concentrations, but stimulates at low concentrations, overview
methylparaben
-
50% inhibition at 0.330 mM
nimesulide
binds near enough to the substrate site to prevent catalysis but not affect dissociation of the substrate-enzyme complex
OrgOD14
-
active substance in Livial (r), above 0.05 mM decreases significantly biosynthesis of estrone by 50-60%, no effect in MDA-MB-231 cells
Promegestone
-
activates SULT1E1 by 26% at low concentrations of 500 nM, inhibits at 0.05 mM by 41%, leads to increased and decreased expression levels, respetively; biphasic effect, inhibits at high concentrations, but stimulates at low concentrations, overview
propylparaben
-
50% inhibition at 0.030 mM
pyridoxal 5'-phosphate
a competitive inhibitor for sulfotransferases
tamoxifen
-
weak inhibition
tibolone
-
activates SULT1E1 in MCF-7 cells by 63% and 44% at low concentrations of 50 nM and 500 nM, respectively, inhibits at 0.05 mM by 64%
trans-resveratrol
-
0.1 mM resveratrol significantly decreases the SULT1E1-mediated beta-estradiol sulfation
17beta-estradiol
-
partial substrate inhibitor
17beta-estradiol
-
17beta-estradiol is a partial kcat-inhibitor (saturation with inhibitor decreases kcat about 7fold without altering Km for PAPS)
2,6-Dichloro-4-nitrophenol
-
-
2,6-Dichloro-4-nitrophenol
DCNP
Mefenamic acid
-
-
quercetin
-
competitive inhibition
quercetin
a potent inhibitor of SULT1E1
resveratrol
-
competitive inhibition
resveratrol
-
inhibits estradiol sulfonation, phytoestrogen with mixed estrogen agonist/antagonist properties developed as a chemopreventive agent, interaction of resveratrol with 17beta-estradiol
additional information
-
3,4,3',4'-tetrachlorbiphenyl is no inhibitor
-
additional information
-
native liver enzyme is less potently inhibited than recombinant SULT1E1
-
additional information
-
low SULT1E1 and/or high steroid sulfatase expression in breast tumor tissue correlates with a poor prognosis for disease progression. Concentrations of isoflavonoids that may be achieved in individuals consuming a high-soy diet may inhibit SULT1E1 activity while exerting no effect on steroid sulfatase
-
additional information
-
no effect by 0.1-1.0% v/v ethanol
-
additional information
-
no inhibition by hydroxybenzoic acid, while butylparaben blocks the skin cytosol sulfation of estradiol and estrone, but not the androgen dehydroepiandrosterone. Structure-activity-relationship of parabens as inhibitors of estrogen sulfation, potency of SULT inhibition increases as the paraben ester chain length increases, overview
-
additional information
not inhibited by isoleoheterin, (-)-8n-acetoxy-15,16-epoxy-8,9-seco-13(16),14-labdadiene-7,9-dione, (-) hispanolone, (+)-leoheterin, (+)-galeopsin, and (+)-sibiricinone B
-
additional information
hydroxylated and sulfated metabolites of commonly occurring airborne polychlorinated biphenyls inhibit human steroid sulfotransferases SULT1E1 and SULT2A1 (EC 2.8.2.2). No inhibition by 4-chloro-4'-hydroxybiphenylsulfate, 2,4'-dichloro-4-hydroxybiphenylsulfate, 3,3'-dichloro-4-hydroxybiphenylsulfate, and 2,2',5,5'-tetrachloro-4-hydroxybiphenylsulfate at up to 0.01 mM
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Forbes-Bamforth, K.J.; Coughtrie, M.W.H.
Identification of a new adult human liver sulfotransferase with specificity for endogenous and xenobiotic estrogens
Biochem. Biophys. Res. Commun.
198
707-711
1994
Homo sapiens
brenda
Chetrite, G.; Pasqualini, J.R.
Steroid sulphotransferase and 17beta-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma cells
J. Steroid Biochem. Mol. Biol.
61
27-34
1997
Homo sapiens
brenda
Nakamura, Y.; Miki, Y.; Suzuki, T.; Nakata, T.; Darnel, A.D.; Moriya, T.; Tazawa, C.; Saito, H.; Ishibashi, T.; Takahashi, S.; Yamada, S.; Sasano, H.
Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta
Am. J. Pathol.
163
1329-1339
2003
Homo sapiens
brenda
Tseng, L.; Lee, L.Y.; Mazella, J.
Estrogen sulfotransferase in human placenta
J. Steroid Biochem.
22
611-615
1985
Homo sapiens
brenda
Hondoh, T.; Suzuki, T.; Hirato, K.; Saitoh, H.; Kadofuku, T.; Sato, T.; Yanahara, T.
Purification and properties of estrogen sulfotransferase of human fetal liver
Biomed. Res.
14
129-136
1993
Homo sapiens
-
brenda
Aksoy, I.A.; Wood, T.C.; Weinshilboum, R.
Human liver estrogen sulfotransferase: identification by cDNA cloning and expression
Biochem. Biophys. Res. Commun.
200
1621-1629
1994
Homo sapiens
brenda
Bernier, F.; Lopez, S.I.; Labrie, F.; van Luu, T.
Cloning and expression of cDNA encoding human placental estrogen sulfotransferase
Mol. Cell. Endocrinol.
99
R11-R15
1994
Homo sapiens
brenda
Falany, J.L.; Falany, C.N.
Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone
Endocrinology
137
1395-1401
1996
Homo sapiens
brenda
Her, C.; Szumlanski, C.; Aksoy, I.A.; Weinshilboum, R.M.
Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation
Drug Metab. Dispos.
24
1328-1335
1996
Homo sapiens
brenda
Kakuta, Y.; Petrotchenko, E.V.; Pedersen, L.C.; Negishi, M.
The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis
J. Biol. Chem.
273
27325-27330
1998
Homo sapiens
brenda
Zhang, H.; Varlamova, O.; Vargas, F.M.; Falany, C.N.; Leyh, T.S.; Varmalova, O.
Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase
J. Biol. Chem.
273
10888-10892
1998
Homo sapiens
brenda
Chetrite, G.S.; Kloosterboer, H.J.; Philippe, J.C.; Pasqualini, J.R.
Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines
Anticancer Res.
19
269-275
1999
Homo sapiens
brenda
Pasqualini, J.R.; Chetrite, G.S.
Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications
J. Steroid Biochem. Mol. Biol.
69
287-292
1999
Homo sapiens
brenda
Qian, Y.; Song, W.C.
Correlation between PAP-dependent steroid binding activity and substrate specificity of mouse and human estrogen sulfotransferases
J. Steroid Biochem. Mol. Biol.
71
123-131
1999
Homo sapiens, Mus musculus
brenda
Hempel, N.; Barnett, A.C.; Bolton-Grob, R.M.; Liyou, N.E.; McManus, M.E.
Site-directed mutagenesis of the substrate-binding cleft of human estrogen sulfotransferase
Biochem. Biophys. Res. Commun.
276
224-230
2000
Homo sapiens
brenda
Kester, M.H.; Bulduk, S.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.; Bergman, A.; Safe, S.H.; Kuiper, G.G.; Schuur, A.G.; Brouwer, A.; Visser, T.J.
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs
Endocrinology
141
1897-1900
2000
Homo sapiens
brenda
Otake, Y.; Nolan, A.L.; Walle, U.K.; Walle, T.
Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells
J. Steroid Biochem. Mol. Biol.
73
265-270
2000
Homo sapiens
brenda
Pai, T.G.; Suiko, M.; Sakakibara, Y.; Liu, M.C.
Sulfation of Flavonoids and Other Phenolic Dietary Compounds by the Human Cytosolic Sulfotransferases
Biochem. Biophys. Res. Commun.
285
1175-1179
2001
Homo sapiens (P49888)
brenda
Song, W.C.
Biochemistry and reproductive endocrinology of estrogen sulfotransferase
Ann. N. Y. Acad. Sci.
948
43-50
2001
Bos taurus, Cavia porcellus, Homo sapiens, Mus musculus, Rattus norvegicus
brenda
Kester, M.H.; Bulduk, S.; van Toor, H.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.; Schuur, A.G.; Brouwer, A.; Visser, T.J.
Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters
J. Clin. Endocrinol. Metab.
87
1142-1150
2002
Homo sapiens
brenda
Pedersen, L.C.; Petrotchenko, E.; Shevtsov, S.; Negishi, M.
Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reaction
J. Biol. Chem.
277
17928-17932
2002
Homo sapiens (P49888)
brenda
van Lipzig, M.M.; Commandeur, J.N.; de Kanter, F.J.; Damsten, M.C.; Vermeulen, N.P.; Maat, E.; Groot, E.J.; Brouwer, A.; Kester, M.H.; Visser, T.J.; Meerman, J.H.
Bioactivation of dibrominated biphenyls by cytochrome P450 activity to metabolites with estrogenic activity and estrogen sulfotransferase inhibition capacity
Chem. Res. Toxicol.
18
1691-1700
2005
Homo sapiens
brenda
Harris, R.M.; Wood, D.M.; Bottomley, L.; Blagg, S.; Owen, K.; Hughes, P.J.; Waring, R.H.; Kirk, C.J.
Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment
J. Clin. Endocrinol. Metab.
89
1779-1787
2004
Homo sapiens
brenda
Stanley, E.L.; Hume, R.; Coughtrie, M.W.H.
Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification
Mol. Cell. Endocrinol.
240
32-42
2005
Homo sapiens
brenda
Pasqualini, J.R.; Chetrite, G.S.
Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast. A hypothesis
Anticancer Res.
27
3219-3225
2007
Homo sapiens
brenda
King, R.S.; Ghosh, A.A.; Wu, J.
Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents
Curr. Drug Metab.
7
745-753
2006
Homo sapiens (P49888)
brenda
Kapoor, R.; Nimmagadda, D.; Sheng, J.J.
Cellular localization studies on human estrogen sulfotransferase SULT1E1 in human embryonic kidney 293 cells
Drug Metab. Dispos.
35
17-20
2007
Homo sapiens, Homo sapiens (P49888)
brenda
Ung, D.; Nagar, S.
Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1
Drug Metab. Dispos.
35
740-746
2007
Homo sapiens, Homo sapiens (P49888)
brenda
Furimsky, A.M.; Green, C.E.; Hunt Sharp, L.E.; Catz, P.; Adjei, A.A.; Parman, T.; Kapetanovic, I.M.; Weinshilboum, R.M.; Iyer, L.V.
Effect of resveratrol on 17{beta}-estradiol sulfation by human hepatic and jejunal S9 and recombinant SULT1E1
Drug Metab. Dispos.
36
129-136
2008
Homo sapiens
brenda
Hoff, R.H.; Czyryca, P.G.; Sun, M.; Leyh, T.S.; Hengge, A.C.
Transition state of the sulfuryl transfer reaction of estrogen sulfotransferase
J. Biol. Chem.
281
30645-30649
2006
Homo sapiens
brenda
Hudelist, G.; Wuelfing, P.; Kersting, C.; Burger, H.; Mattsson, B.; Czerwenka, K.; Kubista, E.; Gschwantler-Kaulich, D.; Fink-Retter, A.; Singer, C.F.
Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer
J. Cancer Res. Clin. Oncol.
134
67-73
2008
Homo sapiens
brenda
Li, L.; Falany, C.N.
Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins
J. Cyst. Fibros.
6
23-30
2007
Homo sapiens, Mus musculus
brenda
Allali-Hassani, A.; Pan, P.W.; Dombrovski, L.; Najmanovich, R.; Tempel, W.; Dong, A.; Loppnau, P.; Martin, F.; Thonton, J.; Edwards, A.M.; Bochkarev, A.; Plotnikov, A.N.; Vedadi, M.; Arrowsmith, C.H.
Structural and chemical profiling of the human cytosolic sulfotransferases
PLoS Biol.
5
1063-1078
2007
Homo sapiens (P49888)
-
brenda
Nakamura, Y.; Suzuki, T.; Fukuda, T.; Ito, A.; Endo, M.; Moriya, T.; Arai, Y.; Sasano, H.
Steroid sulfatase and estrogen sulfotransferase in human prostate cancer
Prostate
66
1005-1012
2006
Homo sapiens
brenda
Wang, M.; Ebmeier, C.C.; Olin, J.R.; Anderson, R.J.
Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)
Steroids
71
343-351
2006
Homo sapiens (P49888)
brenda
Prusakiewicz, J.J.; Harville, H.M.; Zhang, Y.; Ackermann, C.; Voorman, R.L.
Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects
Toxicology
232
248-256
2007
Homo sapiens
brenda
Maiti, S.; Zhang, J.; Chen, G.
Redox regulation of human estrogen sulfotransferase (hSULT1E1)
Biochem. Pharmacol.
73
1474-1481
2007
Homo sapiens
brenda
Hui, Y.; Yasuda, S.; Liu, M.Y.; Wu, Y.Y.; Liu, M.C.
On the sulfation and methylation of catecholestrogens in human mammary epithelial cells and breast cancer cells
Biol. Pharm. Bull.
31
769-773
2008
Homo sapiens
brenda
Svoboda, M.; Sellner, F.; Ekmekcioglu, C.; Klimpfinger, M.; Jaeger, W.; Thalhammer, T.
Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder
Biomed. Pharmacother.
62
690-696
2008
Homo sapiens
brenda
Hirata, H.; Hinoda, Y.; Okayama, N.; Suehiro, Y.; Kawamoto, K.; Kikuno, N.; Rabban, J.T.; Chen, L.M.; Dahiya, R.
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility
Cancer
112
1964-1973
2008
Homo sapiens
brenda
Gong, H.; Jarzynka, M.J.; Cole, T.J.; Lee, J.H.; Wada, T.; Zhang, B.; Gao, J.; Song, W.C.; DeFranco, D.B.; Cheng, S.Y.; Xie, W.
Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase
Cancer Res.
68
7386-7393
2008
Homo sapiens, Mus musculus
brenda
Sato, R.; Suzuki, T.; Katayose, Y.; Miura, K.; Shiiba, K.; Tateno, H.; Miki, Y.; Akahira, J.; Kamogawa, Y.; Nagasaki, S.; Yamamoto, K.; Ii, T.; Egawa, S.; Evans, D.B.; Unno, M.; Sasano, H.
Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors
Cancer Res.
69
914-922
2009
Homo sapiens
brenda
Kapoor, R.; Sheng, J.J.
Transfection of human prostate cancer CA-HPV-10 cells with cytosolic sulfotransferase SULT1E1 affects estrogen signaling and gene transcription
Drug Metab. Dispos.
36
316-321
2008
Homo sapiens
brenda
Cohen, S.; Laitman, Y.; Kaufman, B.; Milgrom, R.; Nir, U.; Friedman, E.
SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women
Fam. Cancer
8
135-144
2008
Homo sapiens
brenda
Gonzalez, A.; Cos, S.; Martinez-Campa, C.; Alonso-Gonzalez, C.; Sanchez-Mateos, S.; Mediavilla, M.D.; Sanchez-Barcelo, E.J.
Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells
J. Pineal Res.
45
86-92
2008
Homo sapiens
brenda
Bacallao, K.; Leon, L.; Gabler, F.; Soto, E.; Romero, C.; Valladares, L.; Vega, M.
In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia
J. Steroid Biochem. Mol. Biol.
110
163-169
2008
Homo sapiens
brenda
Svoboda, M.; Thalhammer, T.; Aust, S.; Arrich, F.; Assadian, O.; Toma, C.D.
Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors
J. Surg. Oncol.
95
572-581
2007
Homo sapiens
brenda
Hudelist, G.; Czerwenka, K.; Keckstein, J.; Haas, C.; Fink-Retter, A.; Gschwantler-Kaulich, D.; Kubista, E.; Singer, C.F.
Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis
Reprod. Sci.
14
798-805
2007
Homo sapiens
brenda
Campisi, I.; Granata, O.M.; Cocciadiferro, L.; Calabro, M.; Polito, L.M.; Carruba, G.
16alpha-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells
Ann. N. Y. Acad. Sci.
1155
237-241
2009
Homo sapiens
brenda
Sasano, H.; Nagasaki, S.; Miki, Y.; Suzuki, T.
New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase
Ann. N. Y. Acad. Sci.
1155
76-79
2009
Homo sapiens
brenda
Pasqualini, J.R.
Estrogen sulfotransferases in breast and endometrial cancers
Ann. N. Y. Acad. Sci.
1155
88-98
2009
Homo sapiens
brenda
Senggunprai, L.; Yoshinari, K.; Yamazoe, Y.
Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases
Biochem. J.
422
455-462
2009
Homo sapiens (P49888)
brenda
He, D.; Wilborn, T.W.; Falany, J.L.; Li, L.; Falany, C.N.
Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes
Biochim. Biophys. Acta
1783
2391-2397
2008
Homo sapiens
brenda
Falany, C.N.; He, D.; Li, L.; Falany, J.L.; Wilborn, T.W.; Kocarek, T.A.; Runge-Morris, M.
Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF)
J. Steroid Biochem. Mol. Biol.
114
113-119
2009
Homo sapiens
brenda
Ung, D.; Nagar, S.
Trans-resveratrol-mediated inhibition of beta-oestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1, and human liver microsomes
Xenobiotica
39
72-79
2009
Homo sapiens
brenda
Suzuki, T.; Miki, Y.; Nakamura, Y.; Ito, K.; Sasano, H.
Steroid sulfatase and estrogen sulfotransferase in human carcinomas
Mol. Cell. Endocrinol.
340
148-153
2011
Homo sapiens
brenda
Sun, M.; Leyh, T.S.
The human estrogen sulfotransferase: a half-site reactive enzyme
Biochemistry
49
4779-4785
2010
Homo sapiens
brenda
Amar, D.; Berger, I.; Amara, N.; Tafa, G.; Meijler, M.M.; Aharoni, A.
The transition of human estrogen sulfotransferase from generalist to specialist using directed enzyme evolution
J. Mol. Biol.
416
21-32
2012
Homo sapiens (P49888)
brenda
Xu, Y.; Yang, X.; Wang, Z.; Li, M.; Ning, Y.; Chen, S.; Yin, L.; Li, X.
Estrogen sulfotransferase (SULT1E1) regulates inflammatory response and lipid metabolism of human endothelial cells via PPARgamma
Mol. Cell. Endocrinol.
369
140-149
2013
Homo sapiens, Homo sapiens (P49888)
brenda
Iida, S.; Kakinuma, H.; Miki, Y.; Abe, K.; Sakurai, M.; Suzuki, S.; Niikawa, H.; Akahira, J.; Suzuki, T.; Sasano, H.
Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma
Br. J. Cancer
108
1415-1424
2013
Homo sapiens
brenda
Rizner, T.L.
The important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Front. Pharmacol.
7
30
2016
Homo sapiens (P49888)
brenda
Narukawa, Y.; Niimura, A.; Noguchi, H.; Tamura, H.; Kiuchi, F.
New diterpenoids with estrogen sulfotransferase inhibitory activity from Leonurus sibiricus L.
J. Nat. Med.
68
125-131
2014
Homo sapiens (P49888)
brenda
Piccinato, C.A.; Neme, R.M.; Torres, N.; Sanches, L.R.; Derogis, P.B.; Brudniewski, H.F.; Rosa e Silva, J.C.; Ferriani, R.A.
Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells
J. Steroid Biochem. Mol. Biol.
158
117-126
2016
Homo sapiens (P49888)
brenda
Ihunnah, C.A.; Wada, T.; Philips, B.J.; Ravuri, S.K.; Gibbs, R.B.; Kirisci, L.; Rubin, J.P.; Marra, K.G.; Xie, W.
Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis
Mol. Cell. Biol.
34
1682-1694
2014
Homo sapiens (P49888)
brenda
Li, Y.; Xu, Y.; Li, X.; Qin, Y.; Hu, R.
Effects of PPAR-alpha agonist and IGF-1 on estrogen sulfotransferase in human vascular endothelial and smooth muscle cells
Mol. Med. Rep.
8
133-139
2013
Homo sapiens (P49888)
brenda
Wang, X.; Chen, X.; Feng, X.; Chang, F.; Chen, M.; Xia, Y.; Chen, L.
Triclosan causes spontaneous abortion accompanied by decline of estrogen sulfotransferase activity in humans and mice
Sci. Rep.
5
18252
2015
Mus musculus, Homo sapiens (P49888)
brenda
Garbacz, W.G.; Jiang, M.; Xie, W.
Sex-dependent role of estrogen sulfotransferase and steroid sulfatase in metabolic homeostasis
Adv. Exp. Med. Biol.
1043
455-469
2017
Homo sapiens (P49888), Mus musculus (P49891), Mus musculus C57BL/6J (P49891)
brenda
Sun, Y.; Machalz, D.; Wolber, G.; Parr, M.; Bureik, M.
Functional expression of all human sulfotransferases in fission yeast, assay development, and structural models for isoforms SULT4A1 and SULT6B1
Biomolecules
10
1-17
2020
Homo sapiens (P49888)
brenda
Yip, C.K.Y.; Bansal, S.; Wong, S.Y.; Lau, A.J.
Identification of galeterone and abiraterone as inhibitors of dehydroepiandrosterone sulfonation catalyzed by human hepatic cytosol, SULT2A1, SULT2B1b, and SULT1E1
Drug Metab. Dispos.
46
470-482
2018
Homo sapiens (P49888)
brenda
Parker, V.S.; Squirewell, E.J.; Lehmler, H.J.; Robertson, L.W.; Duffel, M.W.
Hydroxylated and sulfated metabolites of commonly occurring airborne polychlorinated biphenyls inhibit human steroid sulfotransferases SULT1E1 and SULT2A1
Environ. Toxicol. Pharmacol.
58
196-201
2018
Homo sapiens (P49888)
brenda
Rizner, T.L.
The important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Front. Pharmacol.
7
30
2016
Homo sapiens (P49888)
brenda
Sato, A.; Yamazaki, M.; Watanabe, H.; Sakurai, E.; Ebina, K.
Human estrogen sulfotransferase and its related fluorescently labeled decapeptides specifically interact with oxidized low-density lipoprotein
J. Pept. Sci.
26
e3274
2020
Homo sapiens (P49888), Homo sapiens
brenda
Nazmeen, A.; Maiti, S.
Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations
Mol. Biol. Rep.
45
2571-2584
2018
Homo sapiens (P49888), Homo sapiens, Rattus norvegicus (P52844), Rattus norvegicus Wistar (P52844)
brenda
Nazmeen, A.; Chen, G.; Maiti, S.
Dependence between estrogen sulfotransferase (SULT1E1) and nuclear transcription factor Nrf-2 regulations via oxidative stress in breast cancer
Mol. Biol. Rep.
47
4691-4698
2020
Homo sapiens (P49888)
brenda
Mungenast, F.; Aust, S.; Vergote, I.; Vanderstichele, A.; Sehouli, J.; Braicu, E.; Mahner, S.; Castillo-Tong, D.C.; Zeillinger, R.; Thalhammer, T.
Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
Oncol. Lett.
13
4047-4054
2017
Homo sapiens (P49888)
brenda